{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:52:32Z","timestamp":1740109952404,"version":"3.37.3"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["98-2627-B006-016","NSC 100\u20132627-B-006\u2013012","NSC 101\u20132314-B-006\u2013064-MY3","NSC 99-2627-B-006-014"],"award-info":[{"award-number":["98-2627-B006-016","NSC 100\u20132627-B-006\u2013012","NSC 101\u20132314-B-006\u2013064-MY3","NSC 99-2627-B-006-014"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["104\u20132320-B-006\u2013024","MOST 105-2320-B-006-014"],"award-info":[{"award-number":["104\u20132320-B-006\u2013024","MOST 105-2320-B-006-014"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["D102-35001","D103-35A09","NCKUH-10301003","NCKUH-10509004"],"award-info":[{"award-number":["D102-35001","D103-35A09","NCKUH-10301003","NCKUH-10509004"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jad.2017.05.052","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T09:01:15Z","timestamp":1497085275000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effect of memantine on C-reactive protein and lipid profiles in bipolar disorder"],"prefix":"10.1016","volume":"221","author":[{"given":"Hui Hua","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po See","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiou-Lan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"San-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jau-Shyong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen Kuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-Band","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.05.052_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jad.2014.12.015","article-title":"Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders","volume":"174","author":"Ayorech","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.eurpsy.2007.10.007","article-title":"Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists","volume":"23","author":"Bauer","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib3","first-page":"e314","article-title":"The association between immune activation and manic symptoms in patients with a depressive disorder","volume":"3","author":"Becking","year":"2013","journal-title":"TranslationalPsychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jad.2004.04.006","article-title":"The duration of hypomania in bipolar-II disorder in private practice: methodology and validation","volume":"96","author":"Benazzi","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/jamapsychiatry.2013.1111","article-title":"Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study","volume":"70","author":"Benros","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","article-title":"Insulin resistance and outcome in bipolar disorder","volume":"206","author":"Calkin","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jad.2008.12.018","article-title":"High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan","volume":"117","author":"Chang","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jad.2008.12.018","article-title":"High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan","volume":"117","author":"Chang","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2011.07.239","article-title":"Treatment response and cognitive impairment in major depression: association with C-reactive protein","volume":"26","author":"Chang","year":"2012","journal-title":"Brain, Behav., Immun."},{"key":"10.1016\/j.jad.2017.05.052_bib11","first-page":"1","article-title":"C-reactive protein: a differential biomarker for major depressive disorder and bipolar II disorder","volume":"20","author":"Chang","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jad.2009.12.011","article-title":"The role of valproate in metabolic disturbances in bipolar disorder patients","volume":"124","author":"Chang","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jad.2009.12.011","article-title":"The role of valproate in metabolic disturbances in bipolar disorder patients","volume":"124","author":"Chang","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/11589060-000000000-00000","article-title":"Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder","volume":"31","author":"Citrome","year":"2011","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jad.2017.05.052_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1192\/bjp.bp.111.101931","article-title":"Affective disorders and risk of developing dementia: systematic review","volume":"202","author":"da Silva","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4088\/JCP.14r09007","article-title":"C-Reactive Protein Alterations in Bipolar Disorder: a Meta-Analysis","volume":"76","author":"Darg\u00e9l","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jad.2013.04.039","article-title":"Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder","volume":"150","author":"Dickerson","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib18","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1038\/tp.2014.8","article-title":"Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder","volume":"4","author":"Fillman","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/acps.12211","article-title":"Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review","volume":"129","author":"Fond","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2017.05.052_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4088\/JCP.08r04505","article-title":"Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature","volume":"70","author":"Goldstein","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib21","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1038\/npp.2014.148","article-title":"Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders","volume":"39","author":"Hajek","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2017.05.052_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbi.2009.09.014","article-title":"Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein","volume":"24","author":"Halder","year":"2010","journal-title":"Brain, Behav., Immun."},{"key":"10.1016\/j.jad.2017.05.052_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jad.2012.08.042","article-title":"The prevalence of metabolic syndrome in drug-naive bipolar II disorder patients before and after twelve week pharmacological intervention","volume":"146","author":"Hung Chi","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(02)00324-5","article-title":"The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?","volume":"73","author":"Judd","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2017.05.052_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2014.02.036","article-title":"Stressful life events in bipolar I and II disorder: cause or consequence of mood symptoms?","volume":"161","author":"Koenders","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2011.09.040","article-title":"The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial","volume":"136","author":"Koukopoulos","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2013.08.014","article-title":"The association between depressive symptoms, cognitive function, and inflammation in major depression","volume":"35","author":"Krogh","year":"2014","journal-title":"Brain, Behav., Immun."},{"key":"10.1016\/j.jad.2017.05.052_bib30","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.neurobiolaging.2008.01.008","article-title":"Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up","volume":"30","author":"Laurin","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jad.2017.05.052_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.12.049","article-title":"Can bipolar disorder be viewed as a multi-system inflammatory disease?","volume":"141","author":"Leboyer","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.12.049","article-title":"Can bipolar disorder be viewed as a multi-system inflammatory disease?","volume":"141","author":"Leboyer","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib33","doi-asserted-by":"crossref","first-page":"e66847","DOI":"10.1371\/journal.pone.0066847","article-title":"Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naive Patients with Bipolar II Disorder","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jad.2017.05.052_bib34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jpsychires.2013.06.017","article-title":"Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder","volume":"47","author":"Lee","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2017.05.052_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jad.2010.08.001","article-title":"N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial","volume":"129","author":"Magalhaes","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/mp.2014.180","article-title":"Psychiatric blood biomarkers: avoiding jumping to premature negative or positive conclusions","volume":"20","author":"Niculescu","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.numecd.2009.07.005","article-title":"Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?","volume":"19","author":"Nordestgaard","year":"2009","journal-title":"Nutr., Metab., Cardiovasc. Dis.: NMCD"},{"key":"10.1016\/j.jad.2017.05.052_bib38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2017.05.052_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study","volume":"21","author":"Rapaport","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jad.2011.10.025","article-title":"Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study","volume":"136","author":"Salvi","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/11634390-000000000-00000","article-title":"The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias","volume":"26","author":"Sani","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2017.05.052_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4088\/JCP.10r06710","article-title":"Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression","volume":"73","author":"Sarris","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbi.2009.04.011","article-title":"A prospective evaluation of the directionality of the depression-inflammation relationship","volume":"23","author":"Stewart","year":"2009","journal-title":"Brain, Behav., Immun."},{"key":"10.1016\/j.jad.2017.05.052_bib45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/bdi.12240","article-title":"Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission","volume":"16","author":"Tsai","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.05.052_bib46","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","article-title":"Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators","volume":"170","author":"Vancampfort","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib48","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1038\/tp.2013.119","article-title":"Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application","volume":"4","author":"Watkins","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2017.05.052_bib49","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s11033-014-3087-8","article-title":"CRP gene polymorphism contributes genetic susceptibility to dyslipidemia in Han Chinese population","volume":"41","author":"Wei","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jad.2017.05.052_bib50","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0b013e3181d7b45b","article-title":"Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function","volume":"74","author":"Wersching","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2017.05.052_bib51","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/npp.2009.64","article-title":"Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation","volume":"34","author":"Wu","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2017.05.052_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrn3617","article-title":"Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity","volume":"15","author":"Xanthos","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jad.2017.05.052_bib53","doi-asserted-by":"crossref","first-page":"e0121911","DOI":"10.1371\/journal.pone.0121911","article-title":"Repositioning of Memantine as a Potential Novel Therapeutic Agent against Meningitic E. coli-Induced Pathogenicities through Disease-Associated Alpha7 Cholinergic Pathway and RNA Sequencing-Based Transcriptome Analysis of Host Inflammatory Responses","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716318365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716318365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T03:54:28Z","timestamp":1656215668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032716318365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":53,"alternative-id":["S0165032716318365"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.05.052","relation":{},"ISSN":["0165-0327"],"issn-type":[{"type":"print","value":"0165-0327"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of memantine on C-reactive protein and lipid profiles in bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.05.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}